NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation

Publication Date:
2018-02-22
Publisher:
BMJ Publishing
Electronic ISSN:
2044-6055
Topics:
Medicine
Keywords:
Health policy, Open access, Public health
Published by:
http://group.bmj.com/
_version_ 1836398804005289985
autor Penn, L., Rodrigues, A., Haste, A., Marques, M. M., Budig, K., Sainsbury, K., Bell, R., Araujo-Soares, V., White, M., Summerbell, C., Goyder, E., Brennan, A., Adamson, A. J., Sniehotta, F. F.
beschreibung Objectives Evaluation of the demonstrator phase and first wave roll-out of the National Health Service (NHS) Diabetes Prevention Programme (DPP) in England. To examine: (1) intervention design, provision and fidelity assessment procedures; (2) risk assessment and recruitment pathways and (3) data collection for monitoring and evaluation. To provide recommendations informing decision makers on programme quality, improvements and future evaluation. Design We reviewed programme documents, mapping against the NHS DPP specification and National Institute for Health and Care Excellence (NICE) public health guideline: Type 2 diabetes (T2D) prevention in people at high risk (PH38), conducted qualitative research using individual interviews and focus group discussions with stakeholders and examined recruitment, fidelity and data collection procedures. Setting Seven NHS DPP demonstrator sites and, subsequently, 27 first wave areas across England. Interventions Intensive behavioural intervention with weight loss, diet and physical activity goals. The national programme specifies at least 13 sessions over 9 months, delivered face to face to groups of 15–20 adults with non-diabetic hyperglycaemia, mainly recruited from primary care and NHS Health Checks. Participants Participants for qualitative research were purposively sampled to provide a spread of stakeholder experience. Documents for review were provided via the NHS DPP Management Group. Findings The NHS DPP specification reflected current evidence with a clear framework for service provision. Providers, with national capacity to deliver, supplied intervention plans compliant with this framework. Stakeholders highlighted limitations in fidelity assessment and recruitment and retention challenges, especially in reach and equity, that could adversely impact on implementation. Risk assessment for first wave eligibility differed from NICE guidance. Conclusions The NHS DPP provides an evidence-based behavioural intervention for prevention of T2D in adults at high risk, with capacity to deliver nationally. Framework specification allows for balance between consistency and contextual variation in intervention delivery, with session details devolved to providers. Limitations in fidelity assurance, data collection procedures and recruitment issues could adversely impact on intervention effectiveness and restrict evaluation.
citation_standardnr 6170955
datenlieferant ipn_articles
feed_id 151627
feed_publisher BMJ Publishing
feed_publisher_url http://group.bmj.com/
insertion_date 2018-02-22
journaleissn 2044-6055
publikationsjahr_anzeige 2018
publikationsjahr_facette 2018
publikationsjahr_intervall 7984:2015-2019
publikationsjahr_sort 2018
publisher BMJ Publishing
quelle BMJ Open
relation http://bmjopen.bmj.com/cgi/content/short/8/2/e019467?rss=1
schlagwort Health policy, Open access, Public health
search_space articles
shingle_author_1 Penn, L., Rodrigues, A., Haste, A., Marques, M. M., Budig, K., Sainsbury, K., Bell, R., Araujo-Soares, V., White, M., Summerbell, C., Goyder, E., Brennan, A., Adamson, A. J., Sniehotta, F. F.
shingle_author_2 Penn, L., Rodrigues, A., Haste, A., Marques, M. M., Budig, K., Sainsbury, K., Bell, R., Araujo-Soares, V., White, M., Summerbell, C., Goyder, E., Brennan, A., Adamson, A. J., Sniehotta, F. F.
shingle_author_3 Penn, L., Rodrigues, A., Haste, A., Marques, M. M., Budig, K., Sainsbury, K., Bell, R., Araujo-Soares, V., White, M., Summerbell, C., Goyder, E., Brennan, A., Adamson, A. J., Sniehotta, F. F.
shingle_author_4 Penn, L., Rodrigues, A., Haste, A., Marques, M. M., Budig, K., Sainsbury, K., Bell, R., Araujo-Soares, V., White, M., Summerbell, C., Goyder, E., Brennan, A., Adamson, A. J., Sniehotta, F. F.
shingle_catch_all_1 NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation
Health policy, Open access, Public health
Objectives Evaluation of the demonstrator phase and first wave roll-out of the National Health Service (NHS) Diabetes Prevention Programme (DPP) in England. To examine: (1) intervention design, provision and fidelity assessment procedures; (2) risk assessment and recruitment pathways and (3) data collection for monitoring and evaluation. To provide recommendations informing decision makers on programme quality, improvements and future evaluation. Design We reviewed programme documents, mapping against the NHS DPP specification and National Institute for Health and Care Excellence (NICE) public health guideline: Type 2 diabetes (T2D) prevention in people at high risk (PH38), conducted qualitative research using individual interviews and focus group discussions with stakeholders and examined recruitment, fidelity and data collection procedures. Setting Seven NHS DPP demonstrator sites and, subsequently, 27 first wave areas across England. Interventions Intensive behavioural intervention with weight loss, diet and physical activity goals. The national programme specifies at least 13 sessions over 9 months, delivered face to face to groups of 15–20 adults with non-diabetic hyperglycaemia, mainly recruited from primary care and NHS Health Checks. Participants Participants for qualitative research were purposively sampled to provide a spread of stakeholder experience. Documents for review were provided via the NHS DPP Management Group. Findings The NHS DPP specification reflected current evidence with a clear framework for service provision. Providers, with national capacity to deliver, supplied intervention plans compliant with this framework. Stakeholders highlighted limitations in fidelity assessment and recruitment and retention challenges, especially in reach and equity, that could adversely impact on implementation. Risk assessment for first wave eligibility differed from NICE guidance. Conclusions The NHS DPP provides an evidence-based behavioural intervention for prevention of T2D in adults at high risk, with capacity to deliver nationally. Framework specification allows for balance between consistency and contextual variation in intervention delivery, with session details devolved to providers. Limitations in fidelity assurance, data collection procedures and recruitment issues could adversely impact on intervention effectiveness and restrict evaluation.
Penn, L., Rodrigues, A., Haste, A., Marques, M. M., Budig, K., Sainsbury, K., Bell, R., Araujo-Soares, V., White, M., Summerbell, C., Goyder, E., Brennan, A., Adamson, A. J., Sniehotta, F. F.
BMJ Publishing
2044-6055
20446055
shingle_catch_all_2 NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation
Health policy, Open access, Public health
Objectives Evaluation of the demonstrator phase and first wave roll-out of the National Health Service (NHS) Diabetes Prevention Programme (DPP) in England. To examine: (1) intervention design, provision and fidelity assessment procedures; (2) risk assessment and recruitment pathways and (3) data collection for monitoring and evaluation. To provide recommendations informing decision makers on programme quality, improvements and future evaluation. Design We reviewed programme documents, mapping against the NHS DPP specification and National Institute for Health and Care Excellence (NICE) public health guideline: Type 2 diabetes (T2D) prevention in people at high risk (PH38), conducted qualitative research using individual interviews and focus group discussions with stakeholders and examined recruitment, fidelity and data collection procedures. Setting Seven NHS DPP demonstrator sites and, subsequently, 27 first wave areas across England. Interventions Intensive behavioural intervention with weight loss, diet and physical activity goals. The national programme specifies at least 13 sessions over 9 months, delivered face to face to groups of 15–20 adults with non-diabetic hyperglycaemia, mainly recruited from primary care and NHS Health Checks. Participants Participants for qualitative research were purposively sampled to provide a spread of stakeholder experience. Documents for review were provided via the NHS DPP Management Group. Findings The NHS DPP specification reflected current evidence with a clear framework for service provision. Providers, with national capacity to deliver, supplied intervention plans compliant with this framework. Stakeholders highlighted limitations in fidelity assessment and recruitment and retention challenges, especially in reach and equity, that could adversely impact on implementation. Risk assessment for first wave eligibility differed from NICE guidance. Conclusions The NHS DPP provides an evidence-based behavioural intervention for prevention of T2D in adults at high risk, with capacity to deliver nationally. Framework specification allows for balance between consistency and contextual variation in intervention delivery, with session details devolved to providers. Limitations in fidelity assurance, data collection procedures and recruitment issues could adversely impact on intervention effectiveness and restrict evaluation.
Penn, L., Rodrigues, A., Haste, A., Marques, M. M., Budig, K., Sainsbury, K., Bell, R., Araujo-Soares, V., White, M., Summerbell, C., Goyder, E., Brennan, A., Adamson, A. J., Sniehotta, F. F.
BMJ Publishing
2044-6055
20446055
shingle_catch_all_3 NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation
Health policy, Open access, Public health
Objectives Evaluation of the demonstrator phase and first wave roll-out of the National Health Service (NHS) Diabetes Prevention Programme (DPP) in England. To examine: (1) intervention design, provision and fidelity assessment procedures; (2) risk assessment and recruitment pathways and (3) data collection for monitoring and evaluation. To provide recommendations informing decision makers on programme quality, improvements and future evaluation. Design We reviewed programme documents, mapping against the NHS DPP specification and National Institute for Health and Care Excellence (NICE) public health guideline: Type 2 diabetes (T2D) prevention in people at high risk (PH38), conducted qualitative research using individual interviews and focus group discussions with stakeholders and examined recruitment, fidelity and data collection procedures. Setting Seven NHS DPP demonstrator sites and, subsequently, 27 first wave areas across England. Interventions Intensive behavioural intervention with weight loss, diet and physical activity goals. The national programme specifies at least 13 sessions over 9 months, delivered face to face to groups of 15–20 adults with non-diabetic hyperglycaemia, mainly recruited from primary care and NHS Health Checks. Participants Participants for qualitative research were purposively sampled to provide a spread of stakeholder experience. Documents for review were provided via the NHS DPP Management Group. Findings The NHS DPP specification reflected current evidence with a clear framework for service provision. Providers, with national capacity to deliver, supplied intervention plans compliant with this framework. Stakeholders highlighted limitations in fidelity assessment and recruitment and retention challenges, especially in reach and equity, that could adversely impact on implementation. Risk assessment for first wave eligibility differed from NICE guidance. Conclusions The NHS DPP provides an evidence-based behavioural intervention for prevention of T2D in adults at high risk, with capacity to deliver nationally. Framework specification allows for balance between consistency and contextual variation in intervention delivery, with session details devolved to providers. Limitations in fidelity assurance, data collection procedures and recruitment issues could adversely impact on intervention effectiveness and restrict evaluation.
Penn, L., Rodrigues, A., Haste, A., Marques, M. M., Budig, K., Sainsbury, K., Bell, R., Araujo-Soares, V., White, M., Summerbell, C., Goyder, E., Brennan, A., Adamson, A. J., Sniehotta, F. F.
BMJ Publishing
2044-6055
20446055
shingle_catch_all_4 NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation
Health policy, Open access, Public health
Objectives Evaluation of the demonstrator phase and first wave roll-out of the National Health Service (NHS) Diabetes Prevention Programme (DPP) in England. To examine: (1) intervention design, provision and fidelity assessment procedures; (2) risk assessment and recruitment pathways and (3) data collection for monitoring and evaluation. To provide recommendations informing decision makers on programme quality, improvements and future evaluation. Design We reviewed programme documents, mapping against the NHS DPP specification and National Institute for Health and Care Excellence (NICE) public health guideline: Type 2 diabetes (T2D) prevention in people at high risk (PH38), conducted qualitative research using individual interviews and focus group discussions with stakeholders and examined recruitment, fidelity and data collection procedures. Setting Seven NHS DPP demonstrator sites and, subsequently, 27 first wave areas across England. Interventions Intensive behavioural intervention with weight loss, diet and physical activity goals. The national programme specifies at least 13 sessions over 9 months, delivered face to face to groups of 15–20 adults with non-diabetic hyperglycaemia, mainly recruited from primary care and NHS Health Checks. Participants Participants for qualitative research were purposively sampled to provide a spread of stakeholder experience. Documents for review were provided via the NHS DPP Management Group. Findings The NHS DPP specification reflected current evidence with a clear framework for service provision. Providers, with national capacity to deliver, supplied intervention plans compliant with this framework. Stakeholders highlighted limitations in fidelity assessment and recruitment and retention challenges, especially in reach and equity, that could adversely impact on implementation. Risk assessment for first wave eligibility differed from NICE guidance. Conclusions The NHS DPP provides an evidence-based behavioural intervention for prevention of T2D in adults at high risk, with capacity to deliver nationally. Framework specification allows for balance between consistency and contextual variation in intervention delivery, with session details devolved to providers. Limitations in fidelity assurance, data collection procedures and recruitment issues could adversely impact on intervention effectiveness and restrict evaluation.
Penn, L., Rodrigues, A., Haste, A., Marques, M. M., Budig, K., Sainsbury, K., Bell, R., Araujo-Soares, V., White, M., Summerbell, C., Goyder, E., Brennan, A., Adamson, A. J., Sniehotta, F. F.
BMJ Publishing
2044-6055
20446055
shingle_title_1 NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation
shingle_title_2 NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation
shingle_title_3 NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation
shingle_title_4 NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation
timestamp 2025-06-30T23:32:54.030Z
titel NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation
titel_suche NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation
topic WW-YZ
uid ipn_articles_6170955